173 related articles for article (PubMed ID: 31963842)
1. CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells.
Wen L; Zhao C; Song J; Ma L; Ruan J; Xia X; Chen YE; Zhang J; Ma PX; Xu J
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963842
[TBL] [Abstract][Full Text] [Related]
2. A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression.
Xi L; Schmidt JC; Zaug AJ; Ascarrunz DR; Cech TR
Genome Biol; 2015 Nov; 16():231. PubMed ID: 26553065
[TBL] [Abstract][Full Text] [Related]
3. Functional Loss of
Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
[TBL] [Abstract][Full Text] [Related]
4. Programmable base editing of mutated TERT promoter inhibits brain tumour growth.
Li X; Qian X; Wang B; Xia Y; Zheng Y; Du L; Xu D; Xing D; DePinho RA; Lu Z
Nat Cell Biol; 2020 Mar; 22(3):282-288. PubMed ID: 32066906
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Chiba K; Johnson JZ; Vogan JM; Wagner T; Boyle JM; Hockemeyer D
Elife; 2015 Jul; 4():. PubMed ID: 26194807
[TBL] [Abstract][Full Text] [Related]
6. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression.
Cayuela ML; Flores JM; Blasco MA
EMBO Rep; 2005 Mar; 6(3):268-74. PubMed ID: 15731767
[TBL] [Abstract][Full Text] [Related]
7. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
[TBL] [Abstract][Full Text] [Related]
8. Expression of functional alternative telomerase RNA component gene in mouse brain and in motor neurons cells protects from oxidative stress.
Eitan E; Tamar A; Yossi G; Peleg R; Braiman A; Priel E
Oncotarget; 2016 Nov; 7(48):78297-78309. PubMed ID: 27823970
[TBL] [Abstract][Full Text] [Related]
9. AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC.
Laudadio I; Orso F; Azzalin G; Calabrò C; Berardinelli F; Coluzzi E; Gioiosa S; Taverna D; Sgura A; Carissimi C; Fulci V
EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30591524
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.
Beck S; Jin X; Sohn YW; Kim JK; Kim SH; Yin J; Pian X; Kim SC; Nam DH; Choi YJ; Kim H
Mol Cells; 2011 Jan; 31(1):9-15. PubMed ID: 21193962
[TBL] [Abstract][Full Text] [Related]
11. Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts.
Sun L; Chiang JY; Choi JY; Xiong ZM; Mao X; Collins FS; Hodes RJ; Cao K
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):18983-18993. PubMed ID: 31481614
[TBL] [Abstract][Full Text] [Related]
12. Berberine and RNAi-Targeting Telomerase Reverse Transcriptase (TERT) and/or Telomerase RNA Component (TERC) Caused Oxidation in Colorectal Cancer Cell Line, HCT 116: An Integrative Approach using Molecular and Metabolomic Studies.
Samad MA; Saiman MZ; Abdul Majid N; Karsani SA; Yaacob JS
Cell Biochem Biophys; 2024 Mar; 82(1):153-173. PubMed ID: 38198024
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Mancini A; Xavier-Magalhães A; Woods WS; Nguyen KT; Amen AM; Hayes JL; Fellmann C; Gapinske M; McKinney AM; Hong C; Jones LE; Walsh KM; Bell RJA; Doudna JA; Costa BM; Song JS; Perez-Pinera P; Costello JF
Cancer Cell; 2018 Sep; 34(3):513-528.e8. PubMed ID: 30205050
[TBL] [Abstract][Full Text] [Related]
14. The correlation of TERT expression with c-myc expression in cervical cancer.
Sagawa Y; Nishi H; Isaka K; Fujito A; Takayama M
Cancer Lett; 2001 Jul; 168(1):45-50. PubMed ID: 11368876
[TBL] [Abstract][Full Text] [Related]
15. Compromised Chondrocyte Differentiation Capacity in TERC Knockout Mouse Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer.
Chang WF; Wu YH; Xu J; Sung LY
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870992
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.
Aquilanti E; Kageler L; Watson J; Baird DM; Jones RE; Hodges M; Szegletes ZM; Doench JG; Strathdee CA; Figueroa JRMF; Ligon KL; Beck M; Wen PY; Meyerson M
Neuro Oncol; 2023 Jul; 25(7):1275-1285. PubMed ID: 36694348
[TBL] [Abstract][Full Text] [Related]
17. Nucleolar localization of TERT is unrelated to telomerase function in human cells.
Lin J; Jin R; Zhang B; Chen H; Bai YX; Yang PX; Han SW; Xie YH; Huang PT; Huang C; Huang JJ
J Cell Sci; 2008 Jul; 121(Pt 13):2169-76. PubMed ID: 18522991
[TBL] [Abstract][Full Text] [Related]
18. Telomerase reverse transcriptase has an extratelomeric function in somatic cell reprogramming.
Kinoshita T; Nagamatsu G; Saito S; Takubo K; Horimoto K; Suda T
J Biol Chem; 2014 May; 289(22):15776-87. PubMed ID: 24733392
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP
Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887
[TBL] [Abstract][Full Text] [Related]
20. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
